Ayala Pharmaceuticals Inc (ADXS)

[fbg0316]

Dated May 22, 2018. ADXS didn't put out a PR because it's not really news worthy, as it's just ADXS picking a manufacturing sub contractor essentially. The big question is why has the trial not started and it's been more than a year since we got the IND. ADURO filed their NEO IND after ours yet they've already begun their trial. I still think it's possible that Amgen buys the entire company sooner rather than later. Just look at all the missteps of the incompetent management of ADXS. Amgen could get the technology to market faster and keep it all to themselves.